Wang, L., Fu, S., Naing, A., Meric-Bernstam, F., Morrison, C., Hajjar, J., . . . Kwiatkowski, E. T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy. BMJ Publishing Group.
Chicago Style (17th ed.) CitationWang, Linghua, et al. T-cell Receptor Beta Variable Gene Polymorphism Predicts Immune-related Adverse Events During Checkpoint Blockade Immunotherapy. BMJ Publishing Group.
MLA (9th ed.) CitationWang, Linghua, et al. T-cell Receptor Beta Variable Gene Polymorphism Predicts Immune-related Adverse Events During Checkpoint Blockade Immunotherapy. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.